Date: Thursday 22 November 2012
17.30 - 18.00: registration
18.00 - 19.30: conference
19.30 - 21.30: reception
1st Value Added Medicines Conference – a New Value Proposition for Patients, Healthcare Practitioners and Systems
Date
22 Nov 2017
Address
Renaissance Brussels Hotel
Rue du Parnasse 19
1050 Brussels
BelgiumLinks
Section
Health & Consumers
Event Location
Brussels
Event Description
Many stakeholders believe innovation only leads to generating new molecules, but innovation can also come from other areas such as focusing on improving present molecules which are no longer protected by patent.
There is significant untapped potential in Europe to optimise existing therapies and value added medicines represent an opportunity for patients, healthcare providers, payers, industry and the healthcare systems in general.
Come and join us for the first Value Added Medicines Conference in Brussels to learn more about value added medicines and to discuss the current environment, challenges and opportunities in Europe.
Keynote Speeches
- Tackling wasteful spending on health
Main topics
- Incremental innovation on known molecules – Necessity to address all patient needs?
- Value added medicines – How to capture their value for society
The target audience is policy makers, industry, academics and other stakeholders involved.
The discussion will be on repurposing medicines.
More information and link to registration can be found here.
Events of the week
Jobs
Plastics Europe
Plastics Europe
ARCHE NOAH
Party of European Socialists
European Environmental Bureau
EUI - European University Institute
PAN Europe
Eurosif - The European Sustainable Investment Forum
Sealed Air Belgium N.V.
EURACTIV News
- Kremlin praises Trump for criticising Ukrainian strikes deep into Russia
- Serbia seeks to reduce Russian ownership in oil giant to avoid sanctions
- Jordan to host Syria talks, EU to establish contact with HTS ‘soon’
- Russia and Turkey need each other as Putin’s influence wanes, experts say
- Amid Stellantis jitters and a secular crisis, the French automotive industry is fearing for its survival